Research Article

Evaluating the Prognostic Value of Central Venous-to-Arterial PCO2 Difference in COVID-19 Patients Admitted to the Intensive Care Unit

Abstract

Background: This study aimed to evaluate the relationship between the central venous-to-arterial PCO2 gap, serum lactate level, ScvO2, and prognosis of COVID-19 patients admitted to the intensive care unit. The study was performed in the intensive care unit of Imam Reza Hospital of Mashhad University of Medical Sciences.
Methods: The baseline sample and ABG sample were checked in terms of the PCO2 gap for 3 consecutive days. Lactate serum was also evaluated on the second day. Vital signs, oxygenation status, need for vasopressor, type of respiratory support, and calorie intake were recorded simultaneously. The length of stay in the intensive care unit, the duration of mechanical ventilation, and the patient’s discharge or death were also recorded.
Results: In this study, 147 COVID-19 patients were evaluated, of whom 115 patients died and 32 patients were discharged. The patients’ outcomes were assessed as the normal PCO2 gap (less than 6) and high gap (above 6). There were no significant differences between the high gap and mortality on the first day (p=0.833), second day (p> 0.99), and third day (p=0.82). PCo2 gap was not associated with ICU length of stay, duration of mechanical ventilation, SOFA, and APACHE score. The high gap patients had a significantly lower ScvO2 on the three days. Lactate serum was higher in the dead patients than in those discharged. The P/F ratio was significantly higher on the three days in the discharged patients than in the dead patients.
Conclusion: There is no relationship between the central venous-to-arterial PCO2 gap with the 28-day mortality rate in covid-19 patients.

[1] Pölönen P, Ruokonen E, Hippeläinen M, Pöyhönen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90(5):1052-9.
[2] Ranucci M, Romitti F, Isgrò G, Cotza M, Brozzi S, Boncilli A, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure after coronary operations. The Annals of thoracic surgery. 2005;80(6):2213-20.
[3] Schumacker P, Cain S. The concept of a critical oxygen delivery. J Intensive Care Med. 1987; 13:223-9.
[4] Stoppe C, McDonald B, Benstoem C, Elke G, Meybohm P, Whitlock R, et al. Evaluation of persistent organ dysfunction plus death as a novel composite outcome in cardiac surgical patients. J Cardiothorac Vasc Anesth. 2016;30(1):30-8.
[5] Assuncao MS, Corrêa TD, Bravim Bde A, Silva E. How to choose the therapeutic goals to improve tissue perfusion in septic shock. Einstein (Sao Paulo, Brazil). 2015;13(3):441-7.
[6] Parrillo JE, Dellinger RP. Critical care medicine: principles of diagnosis and management in the adult. Philadelphia, PA: Mosby Elsevier; 2008.
[7] Vallet B, Pinsky MR, Cecconi M. Resuscitation of patients with septic shock: please “mind the gap”! J Intensive Care Med. 2013; 39:1653-5.
[8] Renu K, Prasanna PL, Gopalakrishnan AV. Coronaviruses pathogenesis, comorbidities and multi-organ damage–A review. Life Sci. 2020; 255:117839.
[9] Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19 - A systematic review. Life Sci. 2020; 254:117788.
[10] Moussa MD, Durand A, Leroy G, Vincent L, Lamer A, Gantois G, et al. Central venous-to-arterial PCO2 difference, arteriovenous oxygen content and outcome after adult cardiac surgery with cardiopulmonary bypass: A prospective observational study. Eur J Anaesthesiol. 2019;36(4):279-89.
[11] Al Duhailib Z, Hegazy AF, Lalli R, Fiorini K, Priestap F, Iansavichene A, et al. The Use of Central Venous to Arterial Carbon Dioxide Tension Gap for Outcome Prediction in Critically Ill Patients: A Systematic Review and Meta-Analysis. Crit Care Med. 2020;48(12):1855-61.
[12] Araujo DT, Felice VB, Meregalli AF, Friedman G. Value of Central Venous to Arterial CO(2) Difference after Early Goal-directed Therapy in Septic Shock Patients. Indian journal of Crit Care Med: peer-reviewed, Crit Care Med. 2019; 23(10):449-53.
[13] Rocco IS, Gomes WJ, Viceconte M, Bolzan DW, Moreira RSL, Arena R, et al. Cardiovascular involvement in COVID-19: not to be missed. Braz J Cardiovasc Surg. 2020; 35(4):530-8.
[14] Silbert BI, Litton E, Ho KM. Central venous-to-arterial carbon dioxide gradient as a marker of occult tissue hypoperfusion after major surgery. Anaesth Intensive Care. 2015;43(5):628-34.
[15] Mallat J, Lemyze M, Tronchon L, Vallet B, Thevenin D. Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock. Crit Care Med. 2016;5(1):47-56.
[16] Wittayachamnankul B, Chentanakij B, Sruamsiri K, Chattipakorn N. The role of central venous oxygen saturation, blood lactate, and central venous-to-arterial carbon dioxide partial pressure difference as a goal and prognosis of sepsis treatment. J Crit Care. 2016; 36:223-9.
[17] Costa IB, Bittar CS, Rizk SI, Araújo Filho AE, Santos KA, Machado TI, et al. The heart and COVID-19: what cardiologists need to know. Arq Bras Cardiol. 2020; 114:805-16.
[18] Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers D, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-7.
[19] Fraissé M, Logre E, Pajot O, Mentec H, Plantefève G, Contou D. Thrombotic and hemorrhagic events in critically ill COVID-19 patients: a French monocenter retrospective study. J Crit Care. 2020; 24:1-4.
[20] Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854-87.
[21] Iliescu CA, Grines CL, Herrmann J, Yang EH, Cilingiroglu M, Charitakis K, et al. SCAI Expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologıa intervencionista). Catheterization and cardiovascular interventions: J Soc Cardiovasc Angiogr Interv. 2016;87(5): E202-23.
[22] Hajjar LA, Costa I, Rizk SI, Biselli B, Gomes BR, Bittar CS, et al. Intensive care management of patients with COVID-19: a practical approach. Ann intensive care. 2021;11(1):1-7.
[23] Ltaief Z, Schneider AG, Liaudet L. Pathophysiology and clinical implications of the veno-arterial PCO2 gap. J Crit Care. 2021;25(1):318.
Files
IssueArticle in Press QRcode
SectionResearch Article(s)
Keywords
Central venous-to-arterial PCO2 gap lactate Mortality COVID-19
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Sedaghat A, Sharifzadeh Kermani M, Peivandi Yazdi A, Khazaneha M, Khadem-Rezaiyan M. Evaluating the Prognostic Value of Central Venous-to-Arterial PCO2 Difference in COVID-19 Patients Admitted to the Intensive Care Unit. Arch Anesth & Crit Care. 2024;.